University, Inc.: The Corporate Corruption of Higher EducationBasic Books, 01/08/2008 - 416 páginas Our federal and state tax dollars are going to fund higher education. If corporations kick in a little more, should they be able to dictate the research or own the discoveries? During the past two decades, commercial forces have quietly transformed virtually every aspect of academic life. Corporate funding of universities is growing and the money comes with strings attached. In return for this funding, universities and professors are acting more and more like for-profit patent factories: university funds are shifting from the humanities and the less profitable science departments into research labs, and the skill of teaching is valued less and less. Slowly but surely, universities are abandoning their traditional role as disinterested sources of education, alternative perspectives, and wisdom. This growing influence of corporations over universities affects more than just today's college students (and their parents); it compromises the future of all those whose careers depend on a university education, and all those who will be employed, governed, or taught by the products of American universities. |
Índice
1 | |
The Lessons of History | 25 |
The Birth of the MarketModel U | 49 |
The Republic of Science in Turmoil | 73 |
Are Conflicts of Interest Hazardous to Our Health? | 103 |
The University as Business | 137 |
Dreaming of Silicon Valley | 171 |
8 | 199 |
Preserving the Public | 225 |
Outras edições - Ver tudo
University, Inc: The Corporate Corruption of American Higher Education Jennifer Washburn Pré-visualização limitada - 2005 |
University, Inc.: The Corporate Corruption of Higher Education Jennifer Washburn Pré-visualização indisponível - 2006 |
University, Inc.: The Corporate Corruption of Higher Education Jennifer Washburn Pré-visualização indisponível - 2008 |
Palavras e frases frequentes
academia academic administrators academic freedom academic research administrators agreement American University April atrazine AUTM basic Bayh-Dole Act Berkeley Berkeley’s biotech biotechnology Center Chronicle of Higher College Columbia commercial Committee company’s competition conflicts of interest corporate David dean discovery drug economic Eisenberg engineering faculty federal government financial conflicts firms funding Genentech genetic government’s graduate students grants Harvard Health Higher Education Hofstadter human Ibid industry innovation institutions intellectual property inventions investigators Kahn Kern knowledge Latker Medical School Michael Rothenberg Microfibres million National Science Board National Science Foundation Nelson Nolan Novartis patenting and licensing percent Personal interview pharmaceutical president professors profits programs proprietary Rausser Rebecca Eisenberg Review Richard Richard Florida role Rothenberg scientific scientists Senate sponsor Stanford teaching tech-transfer office Technology Transfer tion told U.C. Berkeley U.S. Congress University-Industry university’s Washington wrote York Zapol